Mohammed Abbas

1- Sales increased from 2.5 Million / 2001 to 186 Million / 2009.
2- Delta Pharma became No.12 in the sold unit till 6/2010 (YTD) with 61% Growth
(No.1 in the Egyptian Ph.Co.).
3- Delta Pharma became No.21 in sales Vol. (L.E.) with Gr% 46% ( No.2 )
4- Dolphin family brand name became No.1 (Sold unit) in NSAID segment.
5- Dolphin Ped.suppositories became No.1 as analgesic & anti inflammatory with more than 13 Million Box / year.
6- Navoproxin became No.1 in the segment of antiemetic according to I.MS data (Cyclizine & Meclizine gp.).
7- Glimadel became No.5 as oral antidiabetics
8- Desa (after 2 years from its launch) became No.12 in oral antihist.
9- Rovac became No.8 oral antibiotic in macrolides gp.
10- I built & organized a powerful & strong organization with ability to compete
With any other company & products.
11- I started the successful participation for export to morchious, Yemen, Libya.

1- Sales increased from 2.5 Million / 2001 to 186 Million / 2009.
2- Delta Pharma became No.12 in the sold unit till 6/2010 (YTD) with 61% Growth
(No.1 in the Egyptian Ph.Co.).
3- Delta Pharma became No.21 in sales Vol. (L.E.) with Gr% 46% ( No.2 )
4- Dolphin family brand name became No.1 (Sold unit) in NSAID segment.
5- Dolphin Ped.suppositories became No.1 as analgesic & anti inflammatory with more than 13 Million Box / year.
6- Navoproxin became No.1 in the segment of antiemetic according to I.MS data (Cyclizine & Meclizine gp.).
7- Glimadel became No.5 as oral antidiabetics
8- Desa (after 2 years from its launch) became No.12 in oral antihist.
9- Rovac became No.8 oral antibiotic in macrolides gp.
10- I built & organized a powerful & strong organization with ability to compete
With any other company & products.
11- I started the successful participation for export to morchious, Yemen, Libya.

provide all requirments of consultation for the sales & marketing Departments